View Filing Data

Print Document View Excel Document

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Feb. 02, 2018	Mar. 02, 2018
Document And Entity Information [Abstract]
Entity Registrant Name	TORO CO
Entity Central Index Key	0000737758
Document Type	10-Q
Document Period End Date	Feb. 02, 2018
Amendment Flag	false
Current Fiscal Year End Date	--10-31
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		106,020,302
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q1

Condensed Consolidated Statements of Earnings (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Feb. 02, 2018	Feb. 03, 2017
Income Statement [Abstract]
Net sales	$ 548,246	$ 515,839
Cost of sales	344,007	322,359
Gross profit	204,239	193,480
Selling, general and administrative expense	137,317	132,910
Operating earnings	66,922	60,570
Interest expense	(4,818)	(4,883)
Other income	4,281	3,866
Earnings before income taxes	66,385	59,553
Provision for income taxes	43,781	14,563
Net earnings	$ 22,604	$ 44,990
Basic net earnings per share of common stock (usd per share)	$ 0.21	$ 0.41
Diluted net earnings per share of common stock (usd per share)	$ 0.21	$ 0.41
Weighted-average number of shares of common stock outstanding — Basic (in shares)	107,225	108,627
Weighted-average number of shares of common stock outstanding — Diluted (in shares)	109,855	110,774

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Feb. 02, 2018	Feb. 03, 2017
Statement of Comprehensive Income [Abstract]
Net earnings	$ 22,604	$ 44,990
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	10,872	117
Derivative instruments, net of tax of $(579) and $285, respectively	(2,779)	221
Other comprehensive income, net of tax	8,093	338
Comprehensive income	$ 30,697	$ 45,328

Condensed Consolidated Statements of Comprehensive Income (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Feb. 02, 2018	Feb. 03, 2017
Statement of Comprehensive Income [Abstract]
Derivative instruments, tax	$ (579)	$ 285

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Feb. 02, 2018	Oct. 31, 2017	Feb. 03, 2017
ASSETS
Cash and cash equivalents	$ 219,730	$ 310,256	$ 158,893
Receivables, net	198,736	183,073	183,850
Inventories, net	439,343	328,992	402,103
Prepaid expenses and other current assets	43,039	37,565	36,470
Total current assets	900,848	859,886	781,316
Property, plant and equipment, gross	883,462	885,614	855,826
Less accumulated depreciation	649,014	650,384	628,909
Property, plant and equipment, net	234,448	235,230	226,917
Deferred income taxes	44,752	64,083	56,864
Goodwill	205,954	205,029	201,246
Other intangible assets, net	102,366	103,743	110,782
Other assets	28,438	25,816	25,788
Total assets	1,516,806	1,493,787	1,402,913
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current portion of long-term debt	13,000	26,258	22,960
Accounts payable	266,586	211,752	232,440
Accrued liabilities	292,903	283,786	263,724
Total current liabilities	572,489	521,796	519,124
Long-term debt, less current portion	302,465	305,629	315,314
Deferred revenue	24,731	24,761	25,172
Deferred income taxes	1,839	1,726	0
Other long-term liabilities	34,501	22,783	30,267
Stockholders’ equity:
Preferred stock, par value $1.00 per share, authorized 1,000,000 voting and 850,000 non-voting shares, none issued and outstanding	0	0	0
Common stock, par value $1.00 per share, authorized 175,000,000 shares; issued and outstanding 106,434,655 shares as of February 2, 2018, 107,575,440 shares as of February 3, 2017, and 106,882,972 shares as of October 31, 2017	106,435	106,883	107,575
Retained earnings	490,373	534,329	443,559
Accumulated other comprehensive loss	(16,027)	(24,120)	(38,098)
Total stockholders’ equity	580,781	617,092	513,036
Total liabilities and stockholders’ equity	$ 1,516,806	$ 1,493,787	$ 1,402,913

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Feb. 02, 2018	Oct. 31, 2017	Feb. 03, 2017
Preferred stock
Preferred stock, par value (in dollars per share)	$ 1.00	$ 1.00	$ 1.00
Preferred stock, issued (in shares)	0	0	0
Preferred stock, outstanding (in shares)	0	0	0
Common stock
Common stock, par value (in dollars per share)	$ 1.00	$ 1.00	$ 1.00
Common stock, authorized (in shares)	175,000,000	175,000,000	175,000,000
Common stock, issued (in shares)	106,434,655	106,882,972	107,575,440
Common stock, outstanding (in shares)	106,434,655	106,882,972	107,575,440
Voting preferred stock
Preferred stock
Preferred stock, authorized (in shares)	1,000,000	1,000,000	1,000,000
Non-voting preferred stock
Preferred stock
Preferred stock, authorized (in shares)	850,000	850,000	850,000

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Feb. 02, 2018	Feb. 03, 2017
Cash flows from operating activities:
Net earnings	$ 22,604	$ 44,990
Adjustments to reconcile net earnings to net cash provided by operating activities:
Non-cash income from finance affiliate	(2,192)	(1,943)
Contributions to finance affiliate, net	(252)	(98)
Provision for depreciation and amortization	15,226	16,516
Stock-based compensation expense	3,124	3,618
Deferred income taxes	19,682	393
Other	(26)	(98)
Changes in operating assets and liabilities, net of effect of acquisitions:
Receivables, net	(12,989)	(19,380)
Inventories, net	(107,017)	(90,560)
Prepaid expenses and other assets	(2,588)	(4,272)
Accounts payable, accrued liabilities, deferred revenue and other long-term liabilities	72,523	66,128
Net cash provided by operating activities	8,095	15,294
Cash flows from investing activities:
Purchases of property, plant and equipment	(10,784)	(11,620)
Acquisition, net of cash acquired	0	(23,882)
Net cash used in investing activities	(10,784)	(35,502)
Cash flows from financing activities:
Payments on long-term debt	(18,017)	(12,702)
Proceeds from exercise of stock options	4,436	3,128
Payments of withholding taxes for stock awards	(3,077)	(2,716)
Purchases of Toro common stock	(50,066)	(65,002)
Dividends paid on Toro common stock	(21,425)	(18,994)
Net cash used in financing activities	(88,149)	(96,286)
Effect of exchange rates on cash and cash equivalents	312	1,832
Net decrease in cash and cash equivalents	(90,526)	(114,662)
Cash and cash equivalents as of the beginning of the fiscal period	310,256	273,555
Cash and cash equivalents as of the end of the fiscal period	$ 219,730	$ 158,893

Basis of Presentation

3 Months Ended

Feb. 02, 2018

Accounting Policies [Abstract]

Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with the instructions to Form 10-Q and do not include all the information and notes required by United States generally accepted accounting principles (“U.S. GAAP”) for complete financial statements. Unless the context indicates otherwise, the terms “company,” “Toro,” “we,” “our” or “us” refer to The Toro Company and its consolidated subsidiaries. All intercompany accounts and transactions have been eliminated from the unaudited Condensed Consolidated Financial Statements.

In the opinion of management, the unaudited Condensed Consolidated Financial Statements include all adjustments, consisting primarily of recurring accruals, considered necessary for the fair presentation of the company's financial position, results of operations, and cash flows for the periods presented. Since the company’s business is seasonal, operating results for the three months ended February 2, 2018 cannot be annualized to determine the expected results for the fiscal year ending October 31, 2018.

The company’s fiscal year ends on October 31, and quarterly results are reported based on three-month periods that generally end on the Friday closest to the quarter end. For comparative purposes, however, the company’s second and third quarters always include exactly 13 weeks of results so that the quarter end date for these two quarters is not necessarily the Friday closest to the calendar month end.

For further information, refer to the Consolidated Financial Statements and Notes to Consolidated Financial Statements included in the company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2017. The policies described in that report are used for preparing quarterly reports.

Accounting Policies

In preparing the Condensed Consolidated Financial Statements in conformity with U.S. GAAP, management must make decisions that impact the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures, including disclosures of contingent assets and liabilities. Such decisions include the selection of the appropriate accounting principles to be applied and the assumptions on which to base accounting estimates. Estimates are used in determining, among other items, sales promotion and incentive accruals, incentive compensation accruals, income tax accruals, inventory valuation, warranty reserves, earn-out liabilities, allowance for doubtful accounts, pension and post-retirement accruals, self-insurance accruals, useful lives for tangible and definite-lived intangible assets, and future cash flows associated with impairment testing for goodwill, indefinite-lived intangible assets and other long-lived assets. These estimates and assumptions are based on management’s best estimates and judgments at the time they are made. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors that management believes to be reasonable under the circumstances, including the current economic environment. Management adjusts such estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with certainty, actual amounts could differ significantly from those estimated at the time the Condensed Consolidated Financial Statements are prepared. Changes in those estimates will be reflected in the Consolidated Financial Statements in future periods.

United States Tax Reform

On December 22, 2017, the United States ("U.S.") enacted Public Law No. 115-97 (“Tax Act”), originally introduced as the Tax Cuts and Jobs Act, to significantly modify the Internal Revenue Code. The Tax Act reduced the U.S. federal corporate tax rate from 35.0 percent to 21.0 percent, created a territorial tax system with an exemption for foreign dividends, and imposed a one-time deemed repatriation tax on a U.S. company's historical undistributed earnings and profits of foreign affiliates. The tax rate change is effective January 1, 2018, resulting in a blended statutory tax rate of 23.3 percent for the fiscal year ended October 31, 2018. Among other provisions, the Tax Act also increased expensing for certain business assets, created new taxes on certain foreign sourced earnings, adopted limitations on business interest expense deductions, repealed deductions for income attributable to domestic production activities, and added other anti-base erosion rules. The effective dates for the provisions set forth in the Tax Act vary as to when the provisions will apply to the company.

In response to the Tax Act, the U.S. Securities and Exchange Commission ("SEC") provided guidance by issuing Staff Accounting Bulletin No. 118 (“SAB 118”). SAB 118 allows companies to record provisional amounts during a measurement period with respect to the impacts of the Tax Act for which the accounting requirements under Accounting Standards Codification ("ASC") Topic 740 are not complete, but a reasonable estimate has been determined. The measurement period under SAB 118 ends when a company has obtained, prepared, and analyzed the information that was needed in order to complete the accounting requirements under ASC Topic 740, but cannot exceed one year.

As of the first quarter of fiscal 2018, the company has not completed the accounting for the effects of the Tax Act. However, the company has estimated the impacts of the Tax Act in its annual effective tax rate, and has recorded provisional amounts for the remeasurement of deferred tax assets and liabilities and the deemed repatriation tax.

While we have recorded provisional amounts for the items expected to most significantly impact our financial statements this year, our evaluation is not complete and, accordingly, we have not yet reached a final conclusion on the overall impacts of the Tax Act. The company needs additional time to obtain, prepare, and analyze information related to the applicable provisions of the Tax Act. The actual impact of the Tax Act may differ from the provisional amounts, due to, among other things, changes in interpretations and assumptions the company has made, guidance that may be issued, and changes in the company's structure or business model.

New Accounting Pronouncements Adopted

In July 2015, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory. This amended guidance changes the measurement principle for inventory from the lower of cost or market to the lower of cost or net realizable value. The amended guidance was adopted in the first quarter of fiscal 2018. The adoption of this guidance did not have an impact on the company's Condensed Consolidated Financial Statements.

In August 2017, the FASB issued ASU No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities, which amends the hedge accounting recognition, presentation, and effectiveness assessment requirements in ASC Topic 815. The company elected to early adopt this amended guidance using a modified retrospective basis effective November 1, 2017 ("adoption date"). In accordance with the transition provisions of ASU 2017-12, the company is required to eliminate the separate measurement of ineffectiveness for its cash flow hedging instruments existing as of the adoption date through a cumulative effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. The company did not record a cumulative effect adjustment to retained earnings to eliminate prior period ineffectiveness amounts recognized in earnings as no such amounts existed within the company’s previously issued Consolidated Financial Statements.

The impact of the early adoption resulted in the following:

•

The company no longer separately measures and recognizes hedge ineffectiveness within the Consolidated Statements of Earnings. Rather, the company recognizes the entire change in the fair value of highly effective cash flow hedging instruments included in the assessment of hedge effectiveness in other comprehensive income within accumulated other comprehensive loss (“AOCL”) on the Consolidated Balance Sheets. The amounts recorded in AOCL will subsequently be reclassified to net earnings in the Consolidated Statements of Earnings within the same line item as the underlying exposure when the underlying hedged transaction affects net earnings.


•	The company no longer recognizes amounts of hedge components excluded from the assessment of effectiveness (“excluded components”) within other income, net, but instead, on a prospective basis, recognizes and presents excluded components within the same line item in the Consolidated Statements of Earnings as the underlying exposure.


•	The company elected to not change its policy on accounting for excluded components and will continue to recognize changes in the fair value of excluded components currently in net earnings under the mark-to-market approach.

In addition, certain provisions in the amended guidance require modification to existing disclosure requirements on a prospective basis. Refer to Note 12, Derivative Instruments and Hedging Activities, for disclosures relating to the company's derivative instruments and hedging activities.

Acquisition	3 Months Ended
Acquisition	Feb. 02, 2018
Business Combinations [Abstract]
Acquisition	Acquisition Effective January 1, 2017, during the first quarter of fiscal 2017, the company completed the acquisition of all the outstanding shares of Regnerbau Calw GmbH ("Perrot"), a privately held manufacturer of professional irrigation equipment. The addition of these products broadened and strengthened the company's irrigation solutions for the sport, agricultural, and industrial markets. The acquisition was funded with existing foreign cash and cash equivalents. The purchase price of this acquisition was allocated to the identifiable assets acquired and liabilities assumed based on estimates of their fair value, with the excess purchase price recorded as goodwill. This acquisition was immaterial based on the company's Consolidated Financial Condition and Results of Operations.

Investment in Joint Venture	3 Months Ended
Investment in Joint Venture	Feb. 02, 2018
Equity Method Investments and Joint Ventures [Abstract]
Investment in Joint Venture	Investment in Joint Venture In fiscal 2009, the company and TCF Inventory Finance, Inc. (“TCFIF”), a subsidiary of TCF National Bank, established Red Iron Acceptance, LLC (“Red Iron”), a joint venture in the form of a Delaware limited liability company that primarily provides inventory financing to certain distributors and dealers of the company’s products in the United States. On November 29, 2016, during the first quarter of fiscal 2017, the company entered into amended agreements for its Red Iron joint venture with TCFIF. As a result, the amended term of Red Iron will continue until October 31, 2024, subject to two-year extensions thereafter. Either the company or TCFIF may elect not to extend the amended term, or any subsequent term, by giving one-year written notice to the other party. The company owns 45 percent of Red Iron and TCFIF owns 55 percent of Red Iron. The company accounts for its investment in Red Iron under the equity method of accounting. The company and TCFIF each contributed a specified amount of the estimated cash required to enable Red Iron to purchase the company’s inventory financing receivables and to provide financial support for Red Iron’s inventory financing programs. Red Iron borrows the remaining requisite estimated cash utilizing a $550 million secured revolving credit facility established under a credit agreement between Red Iron and TCFIF. The company’s total investment in Red Iron as of February 2, 2018 was $23.1 million. The company has not guaranteed the outstanding indebtedness of Red Iron. The company has agreed to repurchase products repossessed by Red Iron and the TCFIF Canadian affiliate, up to a maximum aggregate amount of $7.5 million in a calendar year. Under the repurchase agreement between Red Iron and the company, Red Iron provides financing for certain dealers and distributors. These transactions are structured as an advance in the form of a payment by Red Iron to the company on behalf of a distributor or dealer with respect to invoices financed by Red Iron. These payments extinguish the obligation of the dealer or distributor to make payment to the company under the terms of the applicable invoice. Under separate agreements between Red Iron and the dealers and distributors, Red Iron provides loans to the dealers and distributors for the advances paid by Red Iron to the company. The net amount of receivables financed for dealers and distributors under this arrangement for the three months ended February 2, 2018 and February 3, 2017 were $386.3 million and $375.0 million, respectively. As of January 31, 2018, Red Iron’s total assets were $463.1 million and total liabilities were $411.8 million.

Inventories

3 Months Ended

Feb. 02, 2018

Inventory Disclosure [Abstract]

Inventories

Inventories are valued at the lower of cost or net realizable value, with cost determined by the last-in, first-out (“LIFO”) method for a majority of the company's inventories and the first-in, first-out (“FIFO”) method for all other inventories. The company establishes a reserve for excess, slow-moving, and obsolete inventory that is equal to the difference between the cost and estimated net realizable value for that inventory. These reserves are based on a review and comparison of current inventory levels to the planned production, as well as planned and historical sales of the inventory.

Inventories were as follows:



(Dollars in thousands)	February 2, 2018		February 3, 2017		October 31, 2017
Raw materials and work in process	$	114,150	$	107,170	$	100,077
Finished goods and service parts	391,994		353,290		295,716
Total FIFO value	506,144		460,460		395,793
Less: adjustment to LIFO value	66,801		58,357		66,801
Total inventories, net	$	439,343	$	402,103	$	328,992

Goodwill and Other Intangible Assets

3 Months Ended

Feb. 02, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangible Assets

The changes in the net carrying amount of goodwill for the first three months of fiscal 2018 were as follows:



(Dollars in thousands)	Professional Segment		Residential Segment		Total
Balance as of October 31, 2017	$	194,464	$	10,565	$	205,029
Translation adjustments	793		132		925
Balance as of February 2, 2018	$	195,257	$	10,697	$	205,954

The components of other intangible assets as of February 2, 2018 were as follows:



(Dollars in thousands)	Gross Carrying Amount		Accumulated Amortization			Net
Patents	$	15,193	$	(11,775	)	$	3,418
Non-compete agreements	6,924		(6,807		)	117
Customer-related	87,742		(20,160		)	67,582
Developed technology	30,370		(27,549		)	2,821
Trade names	2,384		(1,689		)	695
Other	800		(800		)	—
Total amortizable	143,413		(68,780		)	74,633
Non-amortizable - trade names	27,733		—			27,733
Total other intangible assets, net	$	171,146	$	(68,780	)	$	102,366

The components of other intangible assets as of October 31, 2017 were as follows:



(Dollars in thousands)	Gross Carrying Amount		Accumulated Amortization			Net
Patents	$	15,162	$	(11,599	)	$	3,563
Non-compete agreements	6,896		(6,775		)	121
Customer-related	87,461		(18,940		)	68,521
Developed technology	30,212		(26,939		)	3,273
Trade names	2,330		(1,637		)	693
Other	800		(800		)	—
Total amortizable	142,861		(66,690		)	76,171
Non-amortizable - trade names	27,572		—			27,572
Total other intangible assets, net	$	170,433	$	(66,690	)	$	103,743

Amortization expense for intangible assets during the first quarter of fiscal 2018 was $1.9 million, compared to $2.4 million for the same period last fiscal year. Estimated amortization expense for the remainder of fiscal 2018 and succeeding fiscal years is as follows: fiscal 2018 (remainder), $4.8 million; fiscal 2019, $5.8 million; fiscal 2020, $5.3 million; fiscal 2021, $4.9 million; fiscal 2022, $4.7 million; fiscal 2023, $4.7 million; and after fiscal 2023, $44.4 million.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details

Stockholders' Equity

3 Months Ended

Feb. 02, 2018

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Stockholders’ Equity

Accumulated Other Comprehensive Loss

Components of AOCL, net of tax, are as follows:



(Dollars in thousands)	February 2, 2018		February 3, 2017		October 31, 2017
Foreign currency translation adjustments	$	10,162	$	31,177	$	21,303
Pension and post-retirement benefits	2,281		6,495		2,012
Cash flow hedging derivative instruments	3,584		426		805
Total accumulated other comprehensive loss	$	16,027	$	38,098	$	24,120

The components and activity of AOCL for the first three months of fiscal 2018 are as follows:



(Dollars in thousands)	Foreign Currency Translation Adjustments			Pension and Post-Retirement Benefits		Cash Flow Hedging Derivative Instruments			Total
Balance as of October 31, 2017	$	21,303		$	2,012	$	805		$	24,120
Other comprehensive (income) loss before reclassifications	(11,141		)	269		3,612			(7,260		)
Amounts reclassified from AOCL	—			—		(833		)	(833		)
Net current period other comprehensive (income) loss	(11,141		)	269		2,779			(8,093		)
Balance as of February 2, 2018	$	10,162		$	2,281	$	3,584		$	16,027

The components and activity of AOCL for the first three months of fiscal 2017 are as follows:



(Dollars in thousands)	Foreign Currency Translation Adjustments			Pension and Post-Retirement Benefits		Cash Flow Hedging Derivative Instruments			Total
Balance as of October 31, 2016	$	31,430		$	6,359	$	647		$	38,436
Other comprehensive (income) loss before reclassifications	(253		)	136		102			(15		)
Amounts reclassified from AOCL	—			—		(323		)	(323		)
Net current period other comprehensive (income) loss	(253		)	136		(221		)	(338		)
Balance as of February 3, 2017	$	31,177		$	6,495	$	426		$	38,098

For additional information on the components reclassified from AOCL to the respective line items in net earnings for derivative instruments, refer to Note 12, Derivative Instruments and Hedging Activities.

Stock-Based Compensation

3 Months Ended

Feb. 02, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock-Based Compensation

The compensation costs related to stock-based awards were as follows:



(Dollars in thousands)	February 2, 2018		February 3, 2017
Stock option awards	$	1,175	$	1,392
Restricted stock units	1,005		576
Performance share awards	414		1,112
Unrestricted common stock awards	530		538
Total compensation cost for stock-based awards	$	3,124	$	3,618

During the first quarter of fiscal years 2018 and 2017, 8,388 and 11,412 shares, respectively, of fully vested unrestricted common stock awards were granted to certain members of the company's Board of Directors as a component of their compensation for their service on the board and are recorded in selling, general and administrative expense in the Condensed Consolidated Statements of Earnings.

Stock Option Awards

Under The Toro Company Amended and Restated 2010 Equity and Incentive Plan, as amended and restated (the “2010 plan”), stock options are granted with an exercise price equal to the closing price of the company’s common stock on the date of grant, as reported by the New York Stock Exchange. Options are generally granted to executive officers, other employees, and non-employee members of the company’s Board of Directors on an annual basis in the first quarter of the company’s fiscal year. Options generally vest one-third each year over a three-year period and have a ten-year term. Other options granted to certain employees vest in full on the three-year anniversary of the date of grant and have a ten-year term. Compensation expense equal to the grant date fair value is generally recognized for these awards over the vesting period. Stock options granted to executive officers and other employees are subject to accelerated expensing if the option holder meets the retirement definition set forth in the 2010 plan. In that case, the fair value of the options is expensed in the fiscal year of grant because generally the option holder must be employed after the last day of the fiscal year in which the stock options are granted in order for the options to continue to vest following retirement. Similarly, if a non-employee director has served on the company’s Board of Directors for ten full fiscal years or more, the awards vest immediately upon retirement, and therefore, the fair value of the options granted is fully expensed on the date of the grant.

The fair value of each stock option is estimated on the date of grant using the Black-Scholes valuation method with the assumptions noted in the table below. The expected life is a significant assumption as it determines the period for which the risk-free interest rate, stock price volatility, and dividend yield must be applied. The expected life is the average length of time in which executive officers, other employees, and non-employee directors are expected to exercise their stock options, which is primarily based on historical exercise experience. The company groups executive officers and non-employee directors for valuation purposes based on similar historical exercise behavior. Expected stock price volatilities are based on the daily movement of the company’s common stock over the most recent historical period equivalent to the expected life of the option. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury rate over the expected life at the time of grant. Dividend yield is estimated over the expected life based on the company’s historical cash dividends paid, expected future cash dividends and dividend yield, and expected changes in the company’s stock price.

The following table illustrates the weighted-average valuation assumptions for options granted in the following fiscal periods:



	Fiscal 2018	Fiscal 2017
Expected life of option in years	6.05	6.02
Expected stock price volatility	20.60%	22.15%
Risk-free interest rate	2.21%	2.03%
Expected dividend yield	0.97%	1.01%
Per share weighted-average fair value at date of grant	$14.29	$12.55

Performance Share Awards

Under the 2010 Plan, the company grants performance share awards to executive officers and other employees under which they are entitled to receive shares of the company’s common stock contingent on the achievement of performance goals of the company and businesses of the company, which are generally measured over a three-year period. The number of shares of common stock a participant receives will be increased (up to 200 percent of target levels) or reduced (down to zero) based on the level of achievement of performance goals and vest at the end of a three-year period. Performance share awards are generally granted on an annual basis in the first quarter of the company’s fiscal year. Compensation expense is recognized for these awards on a straight-line basis over the vesting period based on the per share fair value as of the date of grant and the probability of achieving each performance goal. The per share fair value of performance share awards granted during the first quarter of fiscal 2018 and 2017 was $65.40 and $54.52, respectively.

Restricted Stock Unit Awards

Under the 2010 plan, restricted stock unit awards are generally granted to certain employees that are not executive officers. Occasionally, restricted stock unit awards may be granted, including to executive officers, in connection with hiring, mid-year promotions, leadership transition, or retention. Restricted stock unit awards generally vest one-third each year over a three-year period, or vest in full on the three-year anniversary of the date of grant. Such awards may have performance-based rather than time-based vesting requirements. Compensation expense equal to the grant date fair value, which is equal to the closing price of the company’s common stock on the date of grant multiplied by the number of shares subject to the restricted stock unit awards, is recognized for these awards over the vesting period. The per share weighted-average fair value of restricted stock unit awards granted during the first three months of fiscal 2018 and 2017 was $65.93 and $56.67, respectively.

Per Share Data

3 Months Ended

Feb. 02, 2018

Earnings Per Share [Abstract]

Per Share Data

Reconciliations of basic and diluted weighted-average shares of common stock outstanding are as follows:



	Three Months Ended
(Shares in thousands)	February 2, 2018	February 3, 2017
Basic
Weighted-average number of shares of common stock	107,173	108,585
Assumed issuance of contingent shares	52	42
Weighted-average number of shares of common stock and assumed issuance of contingent shares	107,225	108,627
Diluted
Weighted-average number of shares of common stock and assumed issuance of contingent shares	107,225	108,627
Effect of dilutive securities	2,630	2,147
Weighted-average number of shares of common stock, assumed issuance of contingent shares, and effect of dilutive securities	109,855	110,774

Incremental shares from options and restricted stock units are computed under the treasury stock method. Options to purchase 305,911 and 317,757 shares of common stock during the first three months of fiscal 2018 and 2017, respectively, were excluded from diluted net earnings per share because they were anti-dilutive.

Segment Data

3 Months Ended

Feb. 02, 2018

Segment Reporting [Abstract]

Segment Data

The presentation of segment information reflects the manner in which management organizes segments for making operating decisions and assessing performance. On this basis, the company has determined it has three reportable business segments: Professional, Residential, and Distribution. The Distribution segment, which consists of a wholly-owned domestic distributorship, has been combined with the company’s corporate activities and elimination of intersegment revenues and expenses that is shown as “Other” in the following tables due to the insignificance of the segment.

The following tables present the summarized financial information concerning the company’s reportable segments:



(Dollars in thousands)
Three Months Ended February 2, 2018	Professional		Residential		Other			Total
Net sales	$	403,669	$	142,507	$	2,070		$	548,246
Intersegment gross sales	6,458		56		(6,514		)	—
Earnings (loss) before income taxes	75,912		15,713		(25,240		)	66,385
Total assets	$	904,597	$	249,845	$	362,364		$	1,516,806



(Dollars in thousands)
Three Months Ended February 3, 2017	Professional		Residential		Other			Total
Net sales	$	371,809	$	140,390	$	3,640		$	515,839
Intersegment gross sales	4,556		74		(4,630		)	—
Earnings (loss) before income taxes	68,166		16,558		(25,171		)	59,553
Total assets	$	854,384	$	243,145	$	305,384		$	1,402,913

The following table presents the details of the Other segment operating loss before income taxes:



	Three Months Ended
(Dollars in thousands)	February 2, 2018			February 3, 2017
Corporate expenses	$	(24,401	)	$	(23,961	)
Interest expense	(4,818		)	(4,883		)
Other income	3,979			3,673
Total Other segment operating loss	$	(25,240	)	$	(25,171	)

Contingencies - Litigation	3 Months Ended
Contingencies - Litigation	Feb. 02, 2018
Loss Contingency [Abstract]
Contingencies - Litigation	Contingencies — Litigation The company is party to litigation in the ordinary course of business. Such matters are generally subject to uncertainties and to outcomes that are not predictable with assurance and that may not be known for extended periods of time. Litigation occasionally involves claims for punitive, as well as compensatory, damages arising out of the use of the company’s products. Although the company is self-insured to some extent, the company maintains insurance against certain product liability losses. The company is also subject to litigation and administrative and judicial proceedings with respect to claims involving asbestos and the discharge of hazardous substances into the environment. Some of these claims assert damages and liability for personal injury, remedial investigations or clean up and other costs and damages. The company is also typically involved in commercial disputes, employment disputes, and patent litigation cases in which it is asserting or defending against patent infringement claims. To prevent possible infringement of the company’s patents by others, the company periodically reviews competitors’ products. To avoid potential liability with respect to others’ patents, the company regularly reviews certain patents issued by the United States Patent and Trademark Office and foreign patent offices. Management believes these activities help minimize its risk of being a defendant in patent infringement litigation. The company is currently involved in patent litigation cases, including cases by or against competitors, where it is asserting and defending against claims of patent infringement. Such cases are at varying stages in the litigation process. The company records a liability in its Condensed Consolidated Financial Statements for costs related to claims, including future legal costs, settlements and judgments, where the company has assessed that a loss is probable and an amount can be reasonably estimated. If the reasonable estimate of a probable loss is a range, the company records the most probable estimate of the loss or the minimum amount when no amount within the range is a better estimate than any other amount. The company discloses a contingent liability even if the liability is not probable or the amount is not estimable, or both, if there is a reasonable possibility that a material loss may have been incurred. In the opinion of management, the amount of liability, if any, with respect to these matters, individually or in the aggregate, will not materially affect its Consolidated Results of Operations, Financial Position, or Cash Flows.

Warranty Guarantees

3 Months Ended

Feb. 02, 2018

Product Warranties Disclosures [Abstract]

Warranty Guarantees

The company’s products are warranted to ensure customer confidence in design, workmanship, and overall quality. Warranty coverage is generally for specified periods of time and on select products’ hours of usage, and generally covers parts, labor, and other expenses for non-maintenance repairs. Warranty coverage generally does not cover operator abuse or improper use. An authorized company distributor or dealer must perform warranty work. Distributors and dealers submit claims for warranty reimbursement and are credited for the cost of repairs, labor, and other expenses as long as the repairs meet the company's prescribed standards. Warranty expense is accrued at the time of sale based on the estimated number of products under warranty, historical average costs incurred to service warranty claims, the trend in the historical ratio of claims to sales, the historical length of time between the sale and resulting warranty claim, and other minor factors. Special warranty reserves are also accrued for major rework campaigns. Service support outside of the warranty period is provided by authorized distributors and dealers at the customer's expense. The company sells extended warranty coverage on select products for a prescribed period after the original warranty period expires.

The changes in accrued warranties were as follows:



	Three Months Ended
(Dollars in thousands)	February 2, 2018			February 3, 2017
Beginning balance	$	74,155		$	72,158
Warranty provisions	10,570			9,615
Warranty claims	(9,840		)	(9,794		)
Changes in estimates	—			594
Ending balance	$	74,885		$	72,573

Derivative Instruments and Hedging Activities

3 Months Ended

Feb. 02, 2018

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments and Hedging Activities

Risk Management Objective of Using Derivatives

The company is exposed to foreign currency exchange rate risk arising from transactions in the normal course of business, such as sales to third party customers, sales and loans to wholly owned foreign subsidiaries, foreign plant operations, and purchases from suppliers. The company’s primary currency exchange rate exposures are with the Euro, the Australian dollar, the Canadian dollar, the British pound, the Mexican peso, the Japanese yen, the Chinese Renminbi, and the Romanian New Leu against the U.S. dollar, as well as the Romanian New Leu against the Euro.

To reduce its exposure to foreign currency exchange rate risk, the company actively manages the exposure of its foreign currency exchange rate risk by entering into various derivative instruments to hedge against such risk, authorized under company policies that place controls on these hedging activities, with counterparties that are highly rated financial institutions. The company’s policy does not allow the use of derivative instruments for trading or speculative purposes. The company has also made an accounting policy election to use the portfolio exception with respect to measuring counterparty credit risk for derivative instruments, and to measure the fair value of a portfolio of financial assets and financial liabilities on the basis of the net open risk position with each counterparty.

The company’s hedging activities primarily involve the use of forward currency contracts to hedge most foreign currency transactions, including forecasted sales and purchases denominated in foreign currencies. The company may also utilize forward currency contracts or cross currency swaps to offset intercompany loan exposures. The company uses derivative instruments only in an attempt to limit underlying exposure from foreign currency exchange rate fluctuations and to minimize earnings and cash flow volatility associated with foreign currency exchange rate fluctuations. Decisions on whether to use such derivative instruments are primarily based on the amount of exposure to the currency involved and an assessment of the near-term market value for each currency.

The company recognizes all derivative instruments at fair value on the Condensed Consolidated Balance Sheets as either assets or liabilities. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as a cash flow hedging instrument.

Cash Flow Hedging Instruments

The company formally documents relationships between cash flow hedging instruments and the related hedged transactions, as well as its risk-management objective and strategy for undertaking cash flow hedging instruments. This process includes linking all cash flow hedging instruments to the forecasted transactions, such as sales to third parties, foreign plant operations, and purchases from suppliers. At the cash flow hedge’s inception and on an ongoing basis, the company formally assesses whether the cash flow hedging instruments have been highly effective in offsetting changes in the cash flows of the hedged transactions and whether those cash flow hedging instruments may be expected to remain highly effective in future periods.

Changes in the fair values of the spot rate component of outstanding, highly effective cash flow hedging instruments included in the assessment of hedge effectiveness are recorded in other comprehensive income within AOCL on the Condensed Consolidated Balance Sheets and are subsequently reclassified to net earnings within the Condensed Consolidated Statements of Earnings during the same period in which the cash flows of the underlying hedged transaction affect net earnings. Changes in the fair values of hedge components excluded from the assessment of effectiveness are recognized immediately in net earnings under the mark-to-market approach. The classification of gains or losses recognized on cash flow hedging instruments and excluded components within the Condensed Consolidated Statements of Earnings is the same as that of the underlying exposure. Results of cash flow hedging instruments, and the related excluded components, of sales and foreign plant operations are recorded in net sales and cost of sales, respectively. The maximum amount of time the company hedges its exposure to the variability in future cash flows for forecasted trade sales and purchases is two years. Results of cash flow hedges of intercompany loans are recorded in other income, net as an offset to the remeasurement of the foreign loan balance.

When it is determined that a derivative instrument is not, or has ceased to be, highly effective as a cash flow hedge, the company discontinues cash flow hedge accounting prospectively. The gain or loss on the dedesignated derivative instrument remains in AOCL and is reclassified to net earnings within the same Condensed Consolidated Statements of Earnings line item as the underlying exposure when the forecasted transaction affects net earnings. When the company discontinues cash flow hedge accounting because it is no longer probable, but it is still reasonably possible that the forecasted transaction will occur by the end of the originally expected period or within an additional two-month period of time thereafter, the gain or loss on the derivative instrument remains in AOCL and is reclassified to net earnings within the same Condensed Consolidated Statements of Earnings line item as the underlying exposure when the forecasted transaction affects net earnings. However, if it is probable that a forecasted transaction will not occur by the end of the originally specified time period or within an additional two-month period of time thereafter, the gains and losses that were in AOCL are immediately recognized in net earnings within other income, net in the Condensed Consolidated Statements of Earnings. In all situations in which cash flow hedge accounting is discontinued and the derivative instrument remains outstanding, the company carries the derivative instrument at its fair value on the Condensed Consolidated Balance Sheets, recognizing future changes in the fair value within other income, net in the Condensed Consolidated Statements of Earnings.

As of February 2, 2018, the notional amount outstanding of forward contracts designated as cash flow hedging instruments was $81.5 million.

Derivatives Not Designated as Cash Flow Hedging Instruments

The company also enters into foreign currency contracts that include forward currency contracts to mitigate the remeasurement of specific assets and liabilities on the Condensed Consolidated Balance Sheets. These contracts are not designated as cash flow hedging instruments. Accordingly, changes in the fair value of hedges of recorded balance sheet positions, such as cash, receivables, payables, intercompany notes, and other various contractual claims to pay or receive foreign currencies other than the functional currency, are recognized immediately in other income, net, on the Condensed Consolidated Statements of Earnings together with the transaction gain or loss from the hedged balance sheet position.

The following table presents the fair value and location of the company’s derivative instruments on the Condensed Consolidated Balance Sheets:



(Dollars in thousands)	February 2, 2018		February 3, 2017		October 31, 2017
Derivative assets:
Derivatives designated as cash flow hedging instruments
Prepaid expenses and other current assets
Forward currency contracts	$	974	$	1,552	$	1,014
Derivatives not designated as cash flow hedging instruments
Prepaid expenses and other current assets
Forward currency contracts	180		795		27
Total assets	$	1,154	$	2,347	$	1,041
Derivative liabilities:
Derivatives designated as cash flow hedging instruments
Accrued liabilities
Forward currency contracts	$	5,411	$	1,363	$	1,563
Derivatives not designated as cash flow hedging instruments
Accrued liabilities
Forward currency contracts	2,678		141		703
Total liabilities	$	8,089	$	1,504	$	2,266

The company entered into an International Swap Dealers Association ("ISDA") Master Agreement with each counterparty that permits the net settlement of amounts owed under their respective contracts. The ISDA Master Agreement is an industry standardized contract that governs all derivative contracts entered into between the company and the respective counterparty. Under these master netting agreements, net settlement generally permits the company or the counterparty to determine the net amount payable or receivable for contracts due on the same date or in the same currency for similar types of derivative transactions. The company records the fair value of its derivative instruments at the net amount in its Condensed Consolidated Balance Sheets.

The following table shows the effects of the master netting arrangements on the fair value of the company’s derivative contracts that are recorded in the Condensed Consolidated Balance Sheets:



(Dollars in thousands)	February 2, 2018			February 3, 2017			October 31, 2017
Derivative assets:
Forward currency contracts
Gross amounts of recognized assets	$	1,154		$	2,347		$	1,055
Gross liabilities offset in the balance sheets	—			—			(14		)
Net amounts of assets presented in the Consolidated Balance Sheets	$	1,154		$	2,347		$	1,041
Derivative liabilities:
Forward currency contracts
Gross amounts of recognized liabilities	$	(8,089	)	$	(1,614	)	$	(2,266	)
Gross assets offset in the balance sheets	—			110			—
Net amounts of liabilities presented in the Consolidated Balance Sheets	$	(8,089	)	$	(1,504	)	$	(2,266	)

The following table presents the impact and location of the amounts reclassified from AOCL into earnings on the Condensed Consolidated Statements of Earnings and the impact of derivative instruments on the Condensed Consolidated Statements of Comprehensive Income for the company's derivatives designated as cash flow hedging instruments for the three months ended February 2, 2018 and February 3, 2017:



	Three Months Ended
	Gain (Loss) Reclassified from AOCL into Earnings						Gain (Loss) Recognized in OCI on Derivatives
(Dollars in thousands)	February 2, 2018			February 3, 2017			February 2, 2018			February 3, 2017
Derivatives designated as cash flow hedging instruments
Forward currency contracts
Net sales	$	(1,011	)	$	439		$	(2,678	)	$	(372	)
Cost of sales	178			(762		)	(101		)	(152		)
Total derivatives designated as cash flow hedging instruments	$	(833	)	$	(323	)	$	(2,779	)	$	(524	)

For the first quarter of fiscal 2018 and fiscal 2017, the company did not discontinue cash flow hedge accounting on any forward currency contracts designated as cash flow hedging instruments. As of February 2, 2018, the company expects to reclassify approximately $4.9 million of losses from AOCL to earnings during the next twelve months.

The following table presents the impact and location of derivative instruments on the Condensed Consolidated Statements of Earnings for the company’s derivatives designated as cash flow hedging instruments and the related components excluded from effectiveness testing:



	Gain (Loss) Recognized in Earnings on Cash Flow Hedging Instruments
	February 2, 2018								February 3, 2017
(Dollars in thousands)	Net Sales			Cost of Sales			Other Income, Net		Net Sales		Cost of Sales			Other Income, Net
Total Consolidated Statements of Earnings income (expense) amounts in which the effects of cash flow hedging instruments are recorded	$	548,246		$	(344,007	)	$	4,281	$	515,839	$	(322,359	)	$	3,866
Gain (loss) on derivatives designated as cash flow hedging instruments:
Forward currency contracts
Amount of gain (loss) reclassified from AOCL into earnings	(1,011		)	178			—		439		(762		)	—
Gain (loss) on components excluded from effectiveness testing recognized in earnings based on changes in fair value	$	(21	)	$	(25	)	$	—	$	—	$	—		$	397

The following table presents the impact and location of derivative instruments on the Condensed Consolidated Statements of Earnings for the company’s derivatives not designated as cash flow hedging instruments:



	Three Months Ended
(Dollars in thousands)	February 2, 2018			February 3, 2017
Gain (loss) on derivatives not designated as cash flow hedging instruments
Forward currency contracts
Other income, net	$	(1,816	)	$	1,144
Total gain (loss) on derivatives not designated as cash flow hedging instruments	$	(1,816	)	$	1,144

Fair Value Measurements

3 Months Ended

Feb. 02, 2018

Fair Value Disclosures [Abstract]

Fair Value Measurements

The company categorizes its assets and liabilities measured at fair value into one of three levels based on the assumptions (inputs) used in valuing the asset or liability. Estimates of fair value for financial assets and financial liabilities are based on the framework established in the accounting guidance for fair value measurements. The framework defines fair value, provides guidance for measuring fair value, and requires certain disclosures. The framework discusses valuation techniques such as the market approach (comparable market prices), the income approach (present value of future income or cash flows), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The framework utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. Level 1 provides the most reliable measure of fair value, while Level 3 generally requires significant management judgment. The three levels are defined as follows:

Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities.

Level 2: Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3: Unobservable inputs reflecting management’s assumptions about the inputs used in pricing the asset or liability.

Recurring Fair Value Measurements

The company's derivative instruments consist of forward currency contracts that are measured at fair value on a recurring basis. The fair value of forward currency contracts is determined based on observable market transactions of forward currency prices and spot currency rates as of the reporting date. There were no transfers between levels for the company's recurring fair value measurements during the three months ended February 2, 2018 and February 3, 2017, or the twelve months ended October 31, 2017.

The following tables present, by level within the fair value hierarchy, the company's financial assets and liabilities that are measured at fair value on a recurring basis as of February 2, 2018, February 3, 2017, and October 31, 2017, according to the valuation technique utilized to determine their fair values:



(Dollars in thousands)			Fair Value Measurements Using Inputs Considered as:
February 2, 2018	Fair Value		Level 1		Level 2		Level 3
Assets:
Forward currency contracts	$	1,154	$	—	$	1,154	$	—
Total assets	$	1,154	$	—	$	1,154	$	—
Liabilities:
Forward currency contracts	$	8,089	$	—	$	8,089	$	—
Total liabilities	$	8,089	$	—	$	8,089	$	—



(Dollars in thousands)			Fair Value Measurements Using Inputs Considered as:
February 3, 2017	Fair Value		Level 1		Level 2		Level 3
Assets:
Forward currency contracts	$	2,347	$	—	$	2,347	$	—
Total assets	$	2,347	$	—	$	2,347	$	—
Liabilities:
Forward currency contracts	$	1,504	$	—	$	1,504	$	—
Total liabilities	$	1,504	$	—	$	1,504	$	—



(Dollars in thousands)			Fair Value Measurements Using Inputs Considered as:
October 31, 2017	Fair Value		Level 1		Level 2		Level 3
Assets:
Forward currency contracts	$	1,041	$	—	$	1,041	$	—
Total assets	$	1,041	$	—	$	1,041	$	—
Liabilities:
Forward currency contracts	$	2,266	$	—	$	2,266	$	—
Total liabilities	$	2,266	$	—	$	2,266	$	—

Nonrecurring Fair Value Measurements

The company measures certain assets and liabilities at fair value on a nonrecurring basis. Assets and liabilities that are measured at fair value on a nonrecurring basis include long-lived assets, goodwill and indefinite-lived intangible assets, which are generally recorded at fair value as a result of an impairment charge. Assets acquired and liabilities assumed as part of acquisitions are measured at fair value.

Other Fair Value Measurements

The carrying values of the company's short-term financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, and short-term debt, including current maturities of long-term debt, approximate their fair values due to their short-term nature.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Subsequent Events	3 Months Ended
Subsequent Events	Feb. 02, 2018
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events The company has evaluated all subsequent events and concluded that no subsequent events have occurred that would require recognition in the Condensed Consolidated Financial Statements or disclosure in the Notes to the Condensed Consolidated Financial Statements.

Basis of Presentation (Policies)

3 Months Ended

Feb. 02, 2018

Accounting Policies [Abstract]

Basis of Presentation

Accounting Policies

United States Tax Reform

New Accounting Pronouncements Adopted

The impact of the early adoption resulted in the following:

•


•	The company no longer recognizes amounts of hedge components excluded from the assessment of effectiveness (“excluded components”) within other income, net, but instead, on a prospective basis, recognizes and presents excluded components within the same line item in the Consolidated Statements of Earnings as the underlying exposure.


•	The company elected to not change its policy on accounting for excluded components and will continue to recognize changes in the fair value of excluded components currently in net earnings under the mark-to-market approach.

- Definition

Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.

+ References + Details

Inventories (Tables)

3 Months Ended

Feb. 02, 2018

Inventory Disclosure [Abstract]

Schedule of Inventories

Inventories were as follows:



(Dollars in thousands)	February 2, 2018		February 3, 2017		October 31, 2017
Raw materials and work in process	$	114,150	$	107,170	$	100,077
Finished goods and service parts	391,994		353,290		295,716
Total FIFO value	506,144		460,460		395,793
Less: adjustment to LIFO value	66,801		58,357		66,801
Total inventories, net	$	439,343	$	402,103	$	328,992

Goodwill and Other Intangible Assets (Tables)

3 Months Ended

Feb. 02, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill

The changes in the net carrying amount of goodwill for the first three months of fiscal 2018 were as follows:



(Dollars in thousands)	Professional Segment		Residential Segment		Total
Balance as of October 31, 2017	$	194,464	$	10,565	$	205,029
Translation adjustments	793		132		925
Balance as of February 2, 2018	$	195,257	$	10,697	$	205,954

Schedule of Finite-Lived Intangible Assets

The components of other intangible assets as of February 2, 2018 were as follows:



(Dollars in thousands)	Gross Carrying Amount		Accumulated Amortization			Net
Patents	$	15,193	$	(11,775	)	$	3,418
Non-compete agreements	6,924		(6,807		)	117
Customer-related	87,742		(20,160		)	67,582
Developed technology	30,370		(27,549		)	2,821
Trade names	2,384		(1,689		)	695
Other	800		(800		)	—
Total amortizable	143,413		(68,780		)	74,633
Non-amortizable - trade names	27,733		—			27,733
Total other intangible assets, net	$	171,146	$	(68,780	)	$	102,366

The components of other intangible assets as of October 31, 2017 were as follows:



(Dollars in thousands)	Gross Carrying Amount		Accumulated Amortization			Net
Patents	$	15,162	$	(11,599	)	$	3,563
Non-compete agreements	6,896		(6,775		)	121
Customer-related	87,461		(18,940		)	68,521
Developed technology	30,212		(26,939		)	3,273
Trade names	2,330		(1,637		)	693
Other	800		(800		)	—
Total amortizable	142,861		(66,690		)	76,171
Non-amortizable - trade names	27,572		—			27,572
Total other intangible assets, net	$	170,433	$	(66,690	)	$	103,743

Schedule of Indefinite-Lived Intangible Assets

The components of other intangible assets as of February 2, 2018 were as follows:



(Dollars in thousands)	Gross Carrying Amount		Accumulated Amortization			Net
Patents	$	15,193	$	(11,775	)	$	3,418
Non-compete agreements	6,924		(6,807		)	117
Customer-related	87,742		(20,160		)	67,582
Developed technology	30,370		(27,549		)	2,821
Trade names	2,384		(1,689		)	695
Other	800		(800		)	—
Total amortizable	143,413		(68,780		)	74,633
Non-amortizable - trade names	27,733		—			27,733
Total other intangible assets, net	$	171,146	$	(68,780	)	$	102,366

The components of other intangible assets as of October 31, 2017 were as follows:



(Dollars in thousands)	Gross Carrying Amount		Accumulated Amortization			Net
Patents	$	15,162	$	(11,599	)	$	3,563
Non-compete agreements	6,896		(6,775		)	121
Customer-related	87,461		(18,940		)	68,521
Developed technology	30,212		(26,939		)	3,273
Trade names	2,330		(1,637		)	693
Other	800		(800		)	—
Total amortizable	142,861		(66,690		)	76,171
Non-amortizable - trade names	27,572		—			27,572
Total other intangible assets, net	$	170,433	$	(66,690	)	$	103,743

Stockholders' Equity (Tables)

3 Months Ended

Feb. 02, 2018

Stockholders' Equity Note [Abstract]

Schedule of Components of Accumulated Other Comprehensive Loss (AOCL), Net of Tax

Components of AOCL, net of tax, are as follows:



(Dollars in thousands)	February 2, 2018		February 3, 2017		October 31, 2017
Foreign currency translation adjustments	$	10,162	$	31,177	$	21,303
Pension and post-retirement benefits	2,281		6,495		2,012
Cash flow hedging derivative instruments	3,584		426		805
Total accumulated other comprehensive loss	$	16,027	$	38,098	$	24,120

Schedule of Components and Activity of AOCL

The components and activity of AOCL for the first three months of fiscal 2017 are as follows:



(Dollars in thousands)	Foreign Currency Translation Adjustments			Pension and Post-Retirement Benefits		Cash Flow Hedging Derivative Instruments			Total
Balance as of October 31, 2016	$	31,430		$	6,359	$	647		$	38,436
Other comprehensive (income) loss before reclassifications	(253		)	136		102			(15		)
Amounts reclassified from AOCL	—			—		(323		)	(323		)
Net current period other comprehensive (income) loss	(253		)	136		(221		)	(338		)
Balance as of February 3, 2017	$	31,177		$	6,495	$	426		$	38,098

The components and activity of AOCL for the first three months of fiscal 2018 are as follows:



(Dollars in thousands)	Foreign Currency Translation Adjustments			Pension and Post-Retirement Benefits		Cash Flow Hedging Derivative Instruments			Total
Balance as of October 31, 2017	$	21,303		$	2,012	$	805		$	24,120
Other comprehensive (income) loss before reclassifications	(11,141		)	269		3,612			(7,260		)
Amounts reclassified from AOCL	—			—		(833		)	(833		)
Net current period other comprehensive (income) loss	(11,141		)	269		2,779			(8,093		)
Balance as of February 2, 2018	$	10,162		$	2,281	$	3,584		$	16,027

Stock-Based Compensation (Tables)

3 Months Ended

Feb. 02, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Compensation Cost Related to Stock-Based Awards

The compensation costs related to stock-based awards were as follows:



(Dollars in thousands)	February 2, 2018		February 3, 2017
Stock option awards	$	1,175	$	1,392
Restricted stock units	1,005		576
Performance share awards	414		1,112
Unrestricted common stock awards	530		538
Total compensation cost for stock-based awards	$	3,124	$	3,618

Schedule of Assumptions for Options Granted

The following table illustrates the weighted-average valuation assumptions for options granted in the following fiscal periods:



	Fiscal 2018	Fiscal 2017
Expected life of option in years	6.05	6.02
Expected stock price volatility	20.60%	22.15%
Risk-free interest rate	2.21%	2.03%
Expected dividend yield	0.97%	1.01%
Per share weighted-average fair value at date of grant	$14.29	$12.55

Per Share Data (Tables)

3 Months Ended

Feb. 02, 2018

Earnings Per Share [Abstract]

Reconciliations of basic and diluted weighted-average shares of common stock outstanding

Reconciliations of basic and diluted weighted-average shares of common stock outstanding are as follows:



	Three Months Ended
(Shares in thousands)	February 2, 2018	February 3, 2017
Basic
Weighted-average number of shares of common stock	107,173	108,585
Assumed issuance of contingent shares	52	42
Weighted-average number of shares of common stock and assumed issuance of contingent shares	107,225	108,627
Diluted
Weighted-average number of shares of common stock and assumed issuance of contingent shares	107,225	108,627
Effect of dilutive securities	2,630	2,147
Weighted-average number of shares of common stock, assumed issuance of contingent shares, and effect of dilutive securities	109,855	110,774

Segment Data (Tables)

3 Months Ended

Feb. 02, 2018

Segment Reporting [Abstract]

Summarized Financial Information Concerning Reportable Segments

The following tables present the summarized financial information concerning the company’s reportable segments:



(Dollars in thousands)
Three Months Ended February 2, 2018	Professional		Residential		Other			Total
Net sales	$	403,669	$	142,507	$	2,070		$	548,246
Intersegment gross sales	6,458		56		(6,514		)	—
Earnings (loss) before income taxes	75,912		15,713		(25,240		)	66,385
Total assets	$	904,597	$	249,845	$	362,364		$	1,516,806



(Dollars in thousands)
Three Months Ended February 3, 2017	Professional		Residential		Other			Total
Net sales	$	371,809	$	140,390	$	3,640		$	515,839
Intersegment gross sales	4,556		74		(4,630		)	—
Earnings (loss) before income taxes	68,166		16,558		(25,171		)	59,553
Total assets	$	854,384	$	243,145	$	305,384		$	1,402,913

Summary of Components of Loss Before Income Taxes Included in Other Segment

The following table presents the details of the Other segment operating loss before income taxes:



	Three Months Ended
(Dollars in thousands)	February 2, 2018			February 3, 2017
Corporate expenses	$	(24,401	)	$	(23,961	)
Interest expense	(4,818		)	(4,883		)
Other income	3,979			3,673
Total Other segment operating loss	$	(25,240	)	$	(25,171	)

Warranty Guarantees (Tables)

3 Months Ended

Feb. 02, 2018

Product Warranties Disclosures [Abstract]

Schedule of Warranty Provisions, Claims, and Changes in Estimates

The changes in accrued warranties were as follows:



	Three Months Ended
(Dollars in thousands)	February 2, 2018			February 3, 2017
Beginning balance	$	74,155		$	72,158
Warranty provisions	10,570			9,615
Warranty claims	(9,840		)	(9,794		)
Changes in estimates	—			594
Ending balance	$	74,885		$	72,573

Derivative Instruments and Hedging Activities (Tables)

3 Months Ended

Feb. 02, 2018

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Fair Value of Derivatives and Consolidated Balance Sheet Location

The following table presents the fair value and location of the company’s derivative instruments on the Condensed Consolidated Balance Sheets:



(Dollars in thousands)	February 2, 2018		February 3, 2017		October 31, 2017
Derivative assets:
Derivatives designated as cash flow hedging instruments
Prepaid expenses and other current assets
Forward currency contracts	$	974	$	1,552	$	1,014
Derivatives not designated as cash flow hedging instruments
Prepaid expenses and other current assets
Forward currency contracts	180		795		27
Total assets	$	1,154	$	2,347	$	1,041
Derivative liabilities:
Derivatives designated as cash flow hedging instruments
Accrued liabilities
Forward currency contracts	$	5,411	$	1,363	$	1,563
Derivatives not designated as cash flow hedging instruments
Accrued liabilities
Forward currency contracts	2,678		141		703
Total liabilities	$	8,089	$	1,504	$	2,266

Schedule of Effects of Master Netting Arrangements on Fair Value of Derivative Contracts Recorded in Consolidated Balance Sheets

The following table shows the effects of the master netting arrangements on the fair value of the company’s derivative contracts that are recorded in the Condensed Consolidated Balance Sheets:



(Dollars in thousands)	February 2, 2018			February 3, 2017			October 31, 2017
Derivative assets:
Forward currency contracts
Gross amounts of recognized assets	$	1,154		$	2,347		$	1,055
Gross liabilities offset in the balance sheets	—			—			(14		)
Net amounts of assets presented in the Consolidated Balance Sheets	$	1,154		$	2,347		$	1,041
Derivative liabilities:
Forward currency contracts
Gross amounts of recognized liabilities	$	(8,089	)	$	(1,614	)	$	(2,266	)
Gross assets offset in the balance sheets	—			110			—
Net amounts of liabilities presented in the Consolidated Balance Sheets	$	(8,089	)	$	(1,504	)	$	(2,266	)

Schedule of Impact of Derivative Instruments on Consolidated Statements of Earnings for Derivatives Designated as Cash Flow Hedging Instruments



	Three Months Ended
	Gain (Loss) Reclassified from AOCL into Earnings						Gain (Loss) Recognized in OCI on Derivatives
(Dollars in thousands)	February 2, 2018			February 3, 2017			February 2, 2018			February 3, 2017
Derivatives designated as cash flow hedging instruments
Forward currency contracts
Net sales	$	(1,011	)	$	439		$	(2,678	)	$	(372	)
Cost of sales	178			(762		)	(101		)	(152		)
Total derivatives designated as cash flow hedging instruments	$	(833	)	$	(323	)	$	(2,779	)	$	(524	)



	Gain (Loss) Recognized in Earnings on Cash Flow Hedging Instruments
	February 2, 2018								February 3, 2017
(Dollars in thousands)	Net Sales			Cost of Sales			Other Income, Net		Net Sales		Cost of Sales			Other Income, Net
Total Consolidated Statements of Earnings income (expense) amounts in which the effects of cash flow hedging instruments are recorded	$	548,246		$	(344,007	)	$	4,281	$	515,839	$	(322,359	)	$	3,866
Gain (loss) on derivatives designated as cash flow hedging instruments:
Forward currency contracts
Amount of gain (loss) reclassified from AOCL into earnings	(1,011		)	178			—		439		(762		)	—
Gain (loss) on components excluded from effectiveness testing recognized in earnings based on changes in fair value	$	(21	)	$	(25	)	$	—	$	—	$	—		$	397

Schedule of Impact of Derivative Instruments on Consolidated Statements of Earnings for Derivatives Not Designated as Hedging Instruments



	Three Months Ended
(Dollars in thousands)	February 2, 2018			February 3, 2017
Gain (loss) on derivatives not designated as cash flow hedging instruments
Forward currency contracts
Other income, net	$	(1,816	)	$	1,144
Total gain (loss) on derivatives not designated as cash flow hedging instruments	$	(1,816	)	$	1,144

Fair Value Measurements (Tables)

3 Months Ended

Feb. 02, 2018

Fair Value Disclosures [Abstract]

Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis



(Dollars in thousands)			Fair Value Measurements Using Inputs Considered as:
February 2, 2018	Fair Value		Level 1		Level 2		Level 3
Assets:
Forward currency contracts	$	1,154	$	—	$	1,154	$	—
Total assets	$	1,154	$	—	$	1,154	$	—
Liabilities:
Forward currency contracts	$	8,089	$	—	$	8,089	$	—
Total liabilities	$	8,089	$	—	$	8,089	$	—



(Dollars in thousands)			Fair Value Measurements Using Inputs Considered as:
February 3, 2017	Fair Value		Level 1		Level 2		Level 3
Assets:
Forward currency contracts	$	2,347	$	—	$	2,347	$	—
Total assets	$	2,347	$	—	$	2,347	$	—
Liabilities:
Forward currency contracts	$	1,504	$	—	$	1,504	$	—
Total liabilities	$	1,504	$	—	$	1,504	$	—



(Dollars in thousands)			Fair Value Measurements Using Inputs Considered as:
October 31, 2017	Fair Value		Level 1		Level 2		Level 3
Assets:
Forward currency contracts	$	1,041	$	—	$	1,041	$	—
Total assets	$	1,041	$	—	$	1,041	$	—
Liabilities:
Forward currency contracts	$	2,266	$	—	$	2,266	$	—
Total liabilities	$	2,266	$	—	$	2,266	$	—

Basis of Presentation (Details)	1 Months Ended
Basis of Presentation (Details)	Feb. 02, 2018
Accounting Policies [Abstract]
Blended statutory tax rate	23.30%

Investment in Joint Venture - Narrative (Details) - USD ($)	3 Months Ended
	Feb. 02, 2018	Feb. 03, 2017	Jan. 31, 2018
Red Iron Acceptance, LLC
Schedule of Equity Method Investments
Period of unlimited automatic extensions after the initial term of joint venture	2 years
Period of notice to be given by parties under joint venture for not extending initial term of joint venture	1 year
Portion owned by Toro (as a percent)	45.00%
Portion owned by TCFIF (as a percent)	55.00%
Investment in joint venture	$ 23,100,000
Maximum aggregate amount of products repossessed by Red Iron and the TCFIF Canadian affiliate, entity has agreed to repurchase in a calendar year	7,500,000.0
Net amount of new receivables financed for dealers and distributors	386,300,000	$ 375,000,000
Summarized financial information for Red Iron
Total assets			$ 463,100,000
Total liabilities			$ 411,800,000
Red Iron Acceptance, LLC \| TCFIF secured revolving credit facility
Schedule of Equity Method Investments
Maximum borrowing capacity under credit facility	$ 550,000,000

Inventories - Schedule of Inventory (Details) - USD ($) $ in Thousands	Feb. 02, 2018	Oct. 31, 2017	Feb. 03, 2017
Inventory Disclosure [Abstract]
Raw materials and work in process	$ 114,150	$ 100,077	$ 107,170
Finished goods and service parts	391,994	295,716	353,290
Total FIFO value	506,144	395,793	460,460
Less: adjustment to LIFO value	66,801	66,801	58,357
Total inventories, net	$ 439,343	$ 328,992	$ 402,103

Goodwill and Other Intangible Assets - Changes in Net Carrying Amount of Goodwill (Details) $ in Thousands	3 Months Ended
	Feb. 02, 2018 USD ($)
Changes in the net carrying amount of goodwill
Goodwill, beginning balance	$ 205,029
Translation adjustments	925
Goodwill, ending balance	205,954
Professional Segment
Changes in the net carrying amount of goodwill
Goodwill, beginning balance	194,464
Translation adjustments	793
Goodwill, ending balance	195,257
Residential Segment
Changes in the net carrying amount of goodwill
Goodwill, beginning balance	10,565
Translation adjustments	132
Goodwill, ending balance	$ 10,697

Goodwill and Other Intangible Assets - Components of Other Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended
	Feb. 02, 2018	Feb. 03, 2017	Oct. 31, 2017
Other Intangible Assets
Gross Carrying Amount	$ 143,413		$ 142,861
Accumulated Amortization	(68,780)		(66,690)
Net	74,633		76,171
Non-amortizable - trade names	27,733		27,572
Total other intangible assets, gross	171,146		170,433
Total other intangible assets, net	102,366	$ 110,782	103,743
Amortization expense for intangible assets	1,900	$ 2,400
Estimated amortization expense
Fiscal 2018 (remainder)	4,800
Fiscal 2019	5,800
Fiscal 2020	5,300
Fiscal 2021	4,900
Fiscal 2022	4,700
Fiscal 2023	4,700
After 2023	44,400
Patents
Other Intangible Assets
Gross Carrying Amount	15,193		15,162
Accumulated Amortization	(11,775)		(11,599)
Net	3,418		3,563
Non-compete agreements
Other Intangible Assets
Gross Carrying Amount	6,924		6,896
Accumulated Amortization	(6,807)		(6,775)
Net	117		121
Customer-related
Other Intangible Assets
Gross Carrying Amount	87,742		87,461
Accumulated Amortization	(20,160)		(18,940)
Net	67,582		68,521
Developed technology
Other Intangible Assets
Gross Carrying Amount	30,370		30,212
Accumulated Amortization	(27,549)		(26,939)
Net	2,821		3,273
Trade names
Other Intangible Assets
Gross Carrying Amount	2,384		2,330
Accumulated Amortization	(1,689)		(1,637)
Net	695		693
Other
Other Intangible Assets
Gross Carrying Amount	800		800
Accumulated Amortization	(800)		(800)
Net	$ 0		$ 0

Stockholders' Equity - Components of Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	Feb. 02, 2018	Oct. 31, 2017	Feb. 03, 2017
Accumulated other comprehensive loss (AOCL)
Foreign currency translation adjustments	$ 10,162	$ 21,303	$ 31,177
Pension and post-retirement benefits	2,281	2,012	6,495
Cash flow hedging derivative instruments	3,584	805	426
Total accumulated other comprehensive loss	$ 16,027	$ 24,120	$ 38,098

Stockholders' Equity - Components and Activity of Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended
	Feb. 02, 2018	Feb. 03, 2017
Components and activity of accumulated other comprehensive loss
Balance as of the beginning of the fiscal period	$ (617,092)
Other comprehensive (income) loss before reclassifications	(7,260)
Amounts reclassified from AOCL	(833)
Net current period other comprehensive (income) loss	(8,093)	$ (338)
Balance as of the end of the fiscal period	(580,781)	(513,036)
Accumulated Other Comprehensive Loss
Components and activity of accumulated other comprehensive loss
Balance as of the beginning of the fiscal period	24,120	38,436
Other comprehensive (income) loss before reclassifications		(15)
Amounts reclassified from AOCL		(323)
Net current period other comprehensive (income) loss		(338)
Balance as of the end of the fiscal period	16,027	38,098
Foreign Currency Translation Adjustments
Components and activity of accumulated other comprehensive loss
Balance as of the beginning of the fiscal period	21,303	31,430
Other comprehensive (income) loss before reclassifications	(11,141)	(253)
Amounts reclassified from AOCL	0	0
Net current period other comprehensive (income) loss	(11,141)	(253)
Balance as of the end of the fiscal period	10,162	31,177
Pension and Post-Retirement Benefits
Components and activity of accumulated other comprehensive loss
Balance as of the beginning of the fiscal period	2,012	6,359
Other comprehensive (income) loss before reclassifications	269	136
Amounts reclassified from AOCL	0	0
Net current period other comprehensive (income) loss	269	136
Balance as of the end of the fiscal period	2,281	6,495
Cash Flow Hedging Derivative Instruments
Components and activity of accumulated other comprehensive loss
Balance as of the beginning of the fiscal period	805	647
Other comprehensive (income) loss before reclassifications	3,612	102
Amounts reclassified from AOCL	(833)	(323)
Net current period other comprehensive (income) loss	2,779	(221)
Balance as of the end of the fiscal period	$ 3,584	$ 426

Stock-Based Compensation - Compensation Costs Related to Stock-Based Awards Granted (Details) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Feb. 02, 2018	Feb. 03, 2017
Stock-Based Compensation
Total compensation cost for stock-based awards	$ 3,124	$ 3,618
Stock option awards
Stock-Based Compensation
Total compensation cost for stock-based awards	1,175	1,392
Restricted stock units
Stock-Based Compensation
Total compensation cost for stock-based awards	1,005	576
Performance share awards
Stock-Based Compensation
Total compensation cost for stock-based awards	414	1,112
Unrestricted common stock awards
Stock-Based Compensation
Total compensation cost for stock-based awards	$ 530	$ 538
Board Of Directors \| Unrestricted common stock awards
Stock-Based Compensation
Fully vested unrestricted common stock awards granted (in shares)	8,388	11,412

Stock-Based Compensation - Stock Option Awards (Details) - Stock option awards - $ / shares	3 Months Ended
	Feb. 02, 2018	Feb. 03, 2017
Assumptions for options granted
Expected life of option in years	6 years 20 days	6 years 7 days
Expected stock price volatility (as a percent)	20.60%	22.15%
Risk-free interest rate (as a percent)	2.21%	2.03%
Expected dividend yield (as a percent)	0.97%	1.01%
Weighted-average fair value at date of grant (in dollars per share)	$ 14.29	$ 12.55
Board Of Directors
Stock-Based Compensation
Vesting period	3 years
Term of options	10 years
Vesting (as a percent)	33.33%
Certain Employees
Stock-Based Compensation
Vesting period	3 years
Term of options	10 years
Non-employee members of Board of Directors
Stock-Based Compensation
Requisite service period for non-employee director after which fair value of options granted is fully expensed on the date of grant	10 years

Stock-Based Compensation - Performance Share Awards and Restricted Stock and Restricted Stock Unit Awards (Details) - $ / shares	3 Months Ended
	Feb. 02, 2018	Feb. 03, 2017
Performance share awards
Stock-Based Compensation
Performance goal period	3 years
Weighted-Average Fair Value at Date of Grant
Granted (in dollars per share)	$ 65.40	$ 54.52
Performance share awards \| Maximum
Stock-Based Compensation
Vesting (as a percent)	200.00%
Performance share awards \| Minimum
Stock-Based Compensation
Vesting (as a percent)	0.00%
Restricted stock and restricted stock unit awards
Stock-Based Compensation
Vesting (as a percent)	33.33%
Weighted-Average Fair Value at Date of Grant
Vesting period	3 years
Granted (in dollars per share)	$ 65.93	$ 56.67

Per Share Data - Reconciliations of Basic and Diluted Weighted-Average Share (Details) - shares	3 Months Ended
	Feb. 02, 2018	Feb. 03, 2017
Basic
Weighted-average number of shares of common stock (in shares)	107,173,000	108,585,000
Assumed issuance of contingent shares (in shares)	52,000	42,000
Weighted-average number of shares of common stock and assumed issuance of contingent shares (in shares)	107,225,000	108,627,000
Diluted
Weighted-average number of shares of common stock and assumed issuance of contingent shares (in shares)	107,225,000	108,627,000
Effect of dilutive securities (in shares)	2,630,000	2,147,000
Weighted-average number of shares of common stock, assumed issuance of contingent shares, and effect of dilutive securities (in shares)	109,855,000	110,774,000
Options, restricted stock, and restricted stock units, excluded from the diluted earnings per share (in shares)	305,911	317,757

Segment Data - Summarized Financial Information of Reportable Segments (Details) $ in Thousands	3 Months Ended
	Feb. 02, 2018 USD ($) segment	Feb. 03, 2017 USD ($)	Oct. 31, 2017 USD ($)
Financial information concerning reportable segments
Number of reportable business segments \| segment	3
Net sales	$ 548,246	$ 515,839
Intersegment gross sales	0	0
Earnings (loss) before income taxes	66,385	59,553
Total assets	1,516,806	1,402,913	$ 1,493,787
Operating Segments \| Professional Segment
Financial information concerning reportable segments
Net sales	403,669	371,809
Intersegment gross sales	6,458	4,556
Earnings (loss) before income taxes	75,912	68,166
Total assets	904,597	854,384
Operating Segments \| Residential Segment
Financial information concerning reportable segments
Net sales	142,507	140,390
Intersegment gross sales	56	74
Earnings (loss) before income taxes	15,713	16,558
Total assets	249,845	243,145
Other
Financial information concerning reportable segments
Net sales	2,070	3,640
Intersegment gross sales	(6,514)	(4,630)
Earnings (loss) before income taxes	(25,240)	(25,171)
Total assets	$ 362,364	$ 305,384

Segment Data - Components of Loss before Income Taxes Included in Other (Details) - USD ($) $ in Thousands	3 Months Ended
	Feb. 02, 2018	Feb. 03, 2017
Components of the loss before income taxes included in "Other"
Interest expense	$ (4,818)	$ (4,883)
Other income	4,281	3,866
Earnings before income taxes	66,385	59,553
Other
Components of the loss before income taxes included in "Other"
Corporate expenses	(24,401)	(23,961)
Interest expense	(4,818)	(4,883)
Other income	3,979	3,673
Earnings before income taxes	$ (25,240)	$ (25,171)

Warranty Guarantees - Schedule of Changes in Accrued Warranties (Details) - USD ($) $ in Thousands	3 Months Ended
	Feb. 02, 2018	Feb. 03, 2017
Warranty provisions, claims, and changes in estimates
Beginning balance	$ 74,155	$ 72,158
Warranty provisions	10,570	9,615
Warranty claims	(9,840)	(9,794)
Changes in estimates	0	594
Ending balance	$ 74,885	$ 72,573

Derivative Instruments and Hedging Activities - Narrative (Details) $ in Millions	3 Months Ended
	Feb. 02, 2018 USD ($)
Derivative Instruments, Gain (Loss) [Line Items]
Maximum length of time hedged in cash flow hedge	2 years
Cash flow hedge effectiveness measurement period	2 years
Losses from AOCL to earnings	$ 4.9
Forward currency contracts
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, notional amount	$ 81.5

Derivative Instruments and Hedging Activities - Fair Value and Location of Derivative Instruments (Details) - USD ($) $ in Thousands	Feb. 02, 2018	Oct. 31, 2017	Feb. 03, 2017
Fair value of derivatives
Derivative assets	$ 1,154	$ 1,041	$ 2,347
Derivative liabilities	8,089	2,266	1,504
Forward currency contracts
Fair value of derivatives
Derivative assets	1,154	1,041	2,347
Derivative liabilities	8,089	2,266	1,504
Forward currency contracts \| Derivatives designated as cash flow hedging instruments \| Prepaid expenses and other current assets
Fair value of derivatives
Derivative assets	974	1,014	1,552
Forward currency contracts \| Derivatives designated as cash flow hedging instruments \| Accrued liabilities
Fair value of derivatives
Derivative liabilities	5,411	1,563	1,363
Forward currency contracts \| Derivatives not designated as cash flow hedging instruments \| Prepaid expenses and other current assets
Fair value of derivatives
Derivative assets	180	27	795
Forward currency contracts \| Derivatives not designated as cash flow hedging instruments \| Accrued liabilities
Fair value of derivatives
Derivative liabilities	$ 2,678	$ 703	$ 141

Derivative Instruments and Hedging Activities - Effects of Master Netting Arrangements (Details) - USD ($) $ in Thousands	Feb. 02, 2018	Oct. 31, 2017	Feb. 03, 2017
Derivative assets:
Net amounts of assets presented in the Consolidated Balance Sheets	$ 1,154	$ 1,041	$ 2,347
Derivative liabilities:
Net amounts of liabilities presented in the Consolidated Balance Sheets	(8,089)	(2,266)	(1,504)
Forward currency contracts
Derivative assets:
Gross amounts of recognized assets	1,154	1,055	2,347
Gross liabilities offset in the balance sheets	0	(14)	0
Net amounts of assets presented in the Consolidated Balance Sheets	1,154	1,041	2,347
Derivative liabilities:
Gross amounts of recognized liabilities	(8,089)	(2,266)	(1,614)
Gross assets offset in the balance sheets	0	0	110
Net amounts of liabilities presented in the Consolidated Balance Sheets	$ (8,089)	$ (2,266)	$ (1,504)

Derivative Instruments and Hedging Activities - Impact and Location of Amounts Reclassified from AOCL and Impacts and Location on OCI(Details) - Cash flow hedging - USD ($) $ in Thousands	3 Months Ended
	Feb. 02, 2018	Feb. 03, 2017
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified from AOCL into Earnings	$ (833)	$ (323)
Gain (Loss) Recognized in OCI on Derivatives	(2,779)	(524)
Forward currency contracts \| Net Sales
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified from AOCL into Earnings	(1,011)	439
Gain (Loss) Recognized in OCI on Derivatives	(2,678)	(372)
Forward currency contracts \| Cost of Sales
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified from AOCL into Earnings	178	(762)
Gain (Loss) Recognized in OCI on Derivatives	$ (101)	$ (152)

Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities - Impact and Location of Derivative Instruments for Derivatives Designated as Cash Flow Hedging and the Related Components Excluded From Effectiveness Testing (Details) - Cash flow hedging - USD ($) $ in Thousands	3 Months Ended
	Feb. 02, 2018	Feb. 03, 2017
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified from AOCL into Earnings	$ (833)	$ (323)
Net Sales
Derivative Instruments, Gain (Loss) [Line Items]
Total gain (loss) on derivatives not designated as cash flow hedging instruments	548,246	515,839
Cost of Sales
Derivative Instruments, Gain (Loss) [Line Items]
Total gain (loss) on derivatives not designated as cash flow hedging instruments	(344,007)	(322,359)
Other Income, Net
Derivative Instruments, Gain (Loss) [Line Items]
Total gain (loss) on derivatives not designated as cash flow hedging instruments	4,281	3,866
Forward currency contracts \| Net Sales
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified from AOCL into Earnings	(1,011)	439
Gain (loss) on components excluded from effectiveness testing recognized in earnings based on changes in fair value	(21)	0
Forward currency contracts \| Cost of Sales
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified from AOCL into Earnings	178	(762)
Gain (loss) on components excluded from effectiveness testing recognized in earnings based on changes in fair value	(25)	0
Forward currency contracts \| Other Income, Net
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified from AOCL into Earnings	0	0
Gain (loss) on components excluded from effectiveness testing recognized in earnings based on changes in fair value	$ 0	$ 397

Derivative Instruments and Hedging Activities - Impact and Location of Derivatives Not Designated As Cash Flow Hedging Instruments(Details) - Other Income, Net - Derivatives not designated as cash flow hedging instruments - USD ($) $ in Thousands	3 Months Ended
	Feb. 02, 2018	Feb. 03, 2017
Derivative Instruments, Gain (Loss) [Line Items]
Total gain (loss) on derivatives not designated as cash flow hedging instruments	$ (1,816)	$ 1,144
Forward currency contracts
Derivative Instruments, Gain (Loss) [Line Items]
Total gain (loss) on derivatives not designated as cash flow hedging instruments	$ (1,816)	$ 1,144

Fair Value Measurements - Fair Value Hierarchy (Details) - USD ($)	Feb. 02, 2018	Oct. 31, 2017	Feb. 03, 2017
Assets:
Derivative assets	$ 1,154,000	$ 1,041,000	$ 2,347,000
Liabilities:
Derivative liabilities	8,089,000	2,266,000	1,504,000
Transfer of assets from level 1 to level 2	0	0	0
Transfer of assets from level 2 to level 1	0	0	0
Transfer of liabilities from level 1 to level 2	0	0	0
Transfer of liabilities from level 2 to level 1	0	0	0
Forward currency contracts
Assets:
Derivative assets	1,154,000	1,041,000	2,347,000
Liabilities:
Derivative liabilities	8,089,000	2,266,000	1,504,000
Measured on a recurring basis
Assets:
Total assets	1,154,000	1,041,000	2,347,000
Liabilities:
Total liabilities	8,089,000	2,266,000	1,504,000
Measured on a recurring basis \| Forward currency contracts
Assets:
Derivative assets	1,154,000	1,041,000	2,347,000
Liabilities:
Derivative liabilities	8,089,000	2,266,000	1,504,000
Measured on a recurring basis \| Level 1
Assets:
Total assets	0	0	0
Measured on a recurring basis \| Level 2
Assets:
Total assets	1,154,000	1,041,000	2,347,000
Liabilities:
Total liabilities	8,089,000	2,266,000	1,504,000
Measured on a recurring basis \| Level 2 \| Forward currency contracts
Assets:
Derivative assets	$ 1,154,000	1,041,000	2,347,000
Liabilities:
Derivative liabilities		$ 2,266,000	$ 1,504,000